Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Immunosuppressants - Bangladesh

Bangladesh
  • The Immunosuppressants market in Bangladesh is estimated to witness a significant growth in revenue, projected to reach US$25.30m by 2024.
  • This growth is expected to continue at an annual growth rate of 16.77% from 2024 to 2029, resulting in a market volume of US$54.92m by 2029.
  • When compared globally, it is noteworthy that United States is anticipated to generate the highest revenue in the Immunosuppressants market, with an estimated revenue of US$35.47bn in 2024.
  • The demand for immunosuppressants in Bangladesh has been steadily increasing due to the rising prevalence of autoimmune diseases in the country.

Definition:
The Immunosuppressants market covers drugs which suppress the immune response. These remedies are used in different therapy areas, mainly to treat auto-immune diseases, such as psoriasis. Anti-rejection drugs administered after organ transplantations are also included in this market. Monoclonal antibodies are an important type of immunosuppressant.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Johnson & Johnson, Sanofi, Novartis

In-Scope

  • Drugs to suppress the immune response
  • Immunosuppressants to treat auto-immune diseases, such as psoriasis
  • Anti-rejection drugs

Out-Of-Scope

  • Multiple sclerosis drugs
  • Anti-rheumatic drugs
  • Immuno-oncology drugs
  • Antivirals
  • Antibiotics
  • Corticosteroids
  • HIV drugs
Immunosuppressants: market data & analysis - Cover

Market Insights report

Immunosuppressants: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    As a market data analyst, analyzing the Immunosuppressants market in Bangladesh has shown some interesting trends and developments.

    Customer preferences:
    The demand for Immunosuppressants in Bangladesh is driven by the increasing prevalence of autoimmune diseases and organ transplantation. Patients with autoimmune diseases such as rheumatoid arthritis, psoriasis, and lupus require long-term treatment with Immunosuppressants to manage their symptoms. Moreover, the number of organ transplantations has been increasing in recent years, which has further boosted the demand for Immunosuppressants.

    Trends in the market:
    The Immunosuppressants market in Bangladesh is expected to grow at a steady pace in the coming years. One of the major trends in the market is the increasing adoption of generic Immunosuppressants. The government of Bangladesh has implemented policies to promote the use of generic drugs to reduce healthcare costs. This has led to the entry of several local and international manufacturers of generic Immunosuppressants in the market. The availability of affordable generic Immunosuppressants has made it easier for patients to access treatment, which has further fueled the demand for these drugs.Another trend in the market is the increasing use of combination therapy. Combination therapy involves the use of two or more Immunosuppressants to achieve better treatment outcomes. This approach is becoming more popular in Bangladesh as it has been found to be more effective than monotherapy in some cases. The use of combination therapy has also contributed to the growth of the Immunosuppressants market in Bangladesh.

    Local special circumstances:
    One of the unique aspects of the Immunosuppressants market in Bangladesh is the high prevalence of hepatitis B and C. These viral infections can cause liver damage, which may require liver transplantation. Patients who undergo liver transplantation require Immunosuppressants to prevent rejection of the transplanted organ. The high prevalence of hepatitis B and C has therefore contributed to the growth of the Immunosuppressants market in Bangladesh.

    Underlying macroeconomic factors:
    The healthcare sector in Bangladesh has been growing rapidly in recent years. The government has been investing heavily in healthcare infrastructure and has implemented policies to improve access to healthcare services. This has led to an increase in demand for pharmaceutical products, including Immunosuppressants. Moreover, the growing middle class in Bangladesh has led to an increase in healthcare spending, which has also contributed to the growth of the Immunosuppressants market.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Immunosuppressants: market data & analysis - BackgroundImmunosuppressants: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.